CIHR – Joint Canada-Israel Health Research Program Phase II (2022 funding opportunity) – Registration
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire within your unit
Memorial Deadline: No RIS review required for the Registration
External Deadline: Tuesday 17th, January 2023
Description
Important Dates
| Competition | 202302JCI |
|---|---|
| Registration Deadline | 2023-01-17 |
| Application Deadline | 2023-02-16 |
| Anticipated Notice of Decision | 2023-08-08 |
| Funding Start Date | 2023-11-01 |
Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support cutting-edge research in the biomedical sciences and global health. This second call for proposals under Phase II is directed toward applicants conducting research in the broad area of Communicable Diseases while strengthening capacity in Canada, Israel and in low- and middle-income countries (LMIC).
The Program will support world-class research projects co-led by three principal investigators: one from Canada, one from Israel and one from an eligible LMIC (see IDRC website for the list of eligible countries). The teams will integrate researchers from all three countries with the intention of strengthening scientific capacity, promoting collaboration, equitable partnerships, and scientific excellence in all its diversity. It is expected that the three principal investigators will work together on a cohesive research project with researchers from all three countries equitably contributing to and benefiting from their involvement in the project and the Program.
Additional information can be found at Researchnet.